Article Details
Retrieved on: 2024-03-29 17:28:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Pfizer's post-pandemic public health strategy in the United States, involving a shift in its marketing partnerships to Publicis and IPG, and its $43 billion acquisition of Seagen to enhance its oncology portfolio.
Article found on: www.pharmexec.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here